TY - JOUR T1 - Smartphone-based remote monitoring of vision in macular disease enables early detection of worsening pathology and need for intravitreal therapy JF - BMJ Health & Care Informatics JO - BMJ Health Care Inform DO - 10.1136/bmjhci-2020-100310 VL - 28 IS - 1 SP - e100310 AU - Meriam Islam AU - Stafford Sansome AU - Radha Das AU - Marko Lukic AU - Kelvin Yi Chong Teo AU - Gavin Tan AU - Konstantinos Balaskas AU - Peter B M Thomas AU - Lucas M Bachmann AU - Andrew M Schimel AU - Dawn A Sim Y1 - 2021/05/01 UR - http://informatics.bmj.com/content/28/1/e100310.abstract N2 - Background/aims To assess the outcomes of home monitoring of distortion caused by macular diseases using a smartphone-based application (app), and to examine them with hospital-based assessments of visual acuity (VA), optical coherence tomography-derived central macular thickness (CMT) and the requirement of intravitreal injection therapy.Design Observational study with retrospective analysis of data.Methods Participants were trained in the correct use of the app (Alleye, Oculocare, Zurich, Switzerland) in person or by using video and telephone consultations. Automated threshold-based alerts were communicated based on a traffic light system. A ‘threshold alarm’ was defined as three consecutive ‘red’ scores, and turned into a ‘persistent alarm’ if present for greater than a 7-day period. Changes of VA and CMT, and the requirement for intravitreal therapy after an alarm were examined.Results 245 patients performing a total of 11 592 tests (mean 46.9 tests per user) were included and 85 eyes (164 alarms) examined. Mean drop in VA from baseline was −4.23 letters (95% CI: −6.24 to −2.22; p<0.001) and mean increase in CMT was 29.5 µm (95% CI: −0.08 to 59.13; p=0.051). Sixty-six eyes (78.5%) producing alarms either had a drop in VA, increase in CMT or both and 60.0% received an injection. Eyes with persistent alarms had a greater loss of VA, −4.79 letters (95% CI: −6.73 to −2.85; p<0.001) or greater increase in CMT, +87.8 µm (95% CI: 5.2 to 170.4; p=0.038).Conclusion Smartphone-based self-tests for macular disease may serve as reliable indicators for the worsening of pathology and the need for treatment.All data relevant to the study are included in the article or uploaded as supplemental information. ER -